EGFR and cancer: Tamoxifen resistance is a complex progress involving the inappropriate activation of ER-mediated epidermal growth factor receptor (EGFR) signaling pathway which promotes the proliferation and survival of cancer cells, rendering them cancer stem cell-like properties [1, 5, 18].